We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 235

Industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 16 2014

The Patented Medicine Prices Review Board (PMPRB) has released a new report titled "Generic Drugs in Canada, 2013", which compares the prices of

Sandoz Canada v. Abbott

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

This is an appeal and cross-appeal from a decision of the Federal Court in a proceeding commenced pursuant to the Patented Medicines (Notice of Compliance) Regulations

Court of Appeal upholds decision awarding Section 8 compensation where sales related to “unauthorized indications” Sanofi-Aventis Canada Inc. v. Teva Canada limited, 2014 FCA 69

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 24 2014

Drug: ramipril This was an appeal by Sanofi-Aventis Canada Inc. and Sanofi-Aventis Deutschland GmbH (collectively "Sanofi") from a judgment of the

Damages in tort awarded against Her Majesty in respect of the issuance of an NOC

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • November 25 2014

In 1988, Apotex Inc. (“Apotex”) filed a submission for approval of its trazodone product with Health Canada. The Apotex product was ultimately

Patent Appeal Board has jurisdiction to consider new defects introduced by the applicants amendments made in response to a final action

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 26 2012

The application relates to a dual balloon catheter

Motions judge dismisses appeal from prothonotary on motion to compel

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 28 2011

In the underlying case, Apotex has sued to impeach sanofi’s patent and sanofi and BMS have sued Apotex for infringement

Court of Appeal upholds decision relating to sildenafil use patent

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

Pfizer Ireland Pharmaceuticals v. Apotex Inc., 2014 FCA 13 Drug: VIAGRA sildenafil In Apotex' action for impeachment of the Pfizer patent

Court grants motion to reopen trial and admit new evidence

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • April 27 2011

The Federal Court granted leave to reopen the trial and admit new evidence in a matter under reserve, in which no reasons or judgement have issued

Lilly v. Apotex

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • September 29 2010

Eli Lilly brought suit against Apotex alleging that it infringed eight (8) process patents

Appeal upholds dismissal of request to amend pleadings due to proximity to trial

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • April 4 2014

This case concerns an appeal of a motion to amend pleadings in the s. 8 case described above. The motion had originally been brought three months